Related Experiment Videos
Spinal opioid analgesia. A critical update.
L L Gustafsson1, Z Wiesenfeld-Hallin
1Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital.
Drugs
|June 1, 1988
Summary
Spinal morphine provides longer-lasting pain relief than intravenous doses for postoperative and cancer pain. Further research is needed to define its benefits and risks compared to other opioid administration routes.
Area of Science:
- Pharmacology
- Pain Management
- Neurosurgery
Background:
- Spinal (intrathecal or extrathecal) opioid administration induces long-lasting analgesia in animal models.
- Extrathecal morphine is an established method for managing postoperative and cancer pain.
- Spinal morphine exhibits higher potency and longer duration of action compared to intravenous (IV) administration.
Purpose of the Study:
- To evaluate the efficacy and safety of spinal morphine for pain management.
- To compare spinal morphine with IV morphine for postoperative and cancer pain.
- To determine optimal dosing strategies for spinal morphine.
Main Methods:
- Review of experimental animal models and controlled clinical trials.
- Analysis of pharmacokinetic and pharmacodynamic factors influencing drug response.
- Assessment of clinical experience in cancer pain management.
Main Results:
- Spinal morphine offers superior potency and duration compared to IV morphine.
- Clinical trials confirm longer-lasting analgesia with single-dose spinal morphine versus IV.
- The efficacy of patient-controlled spinal morphine and its long-term safety remain under investigation.
Conclusions:
- Spinal morphine is effective for postoperative and cancer pain but requires careful patient selection.
- Risks associated with replacing oral or IV opioids with spinal opioids need further clarification.
- Well-designed clinical studies are essential to clearly define the advantages of spinal opioid analgesia.
- Individualized spinal morphine dosages are crucial, considering pain intensity and patient-specific factors.